First Trust Dorsey Wright Focus (FV) 25.21 $FV As

New Post Public Reply Private Reply Replies (0) Message Board

Aug 1, 2015 at 3:06 AM

First Trust Dorsey Wright Focus (FV) 25.21 $FV

As Biotech Beats, 6 Top ETF Picks For Rest Of 2015
at Investor's Business Daily - Tue Jul 14, 5:38PM CDT
Biotechnology and pharmaceutical ETFs powered ahead in the past month, handing profits-on-steroids to investors. A wave of mergers, robust pipelines and busier-than-ever hospitals continue to drive these industries forward. The iShares Nasdaq...
SPY: 210.50 (-0.32), EFAV: 67.42 (+0.31), OIL: 9.17 (-0.35), AGG: 109.50 (+0.43), ILMN: 219.30 (+0.43), IBB: 382.53 (+3.73), SHY: 84.86 (+0.09), VNQ: 79.00 (+0.62), FV: 25.21 (+0.12), SDY: 77.53 (+0.06)

HBO Now Is a Hit on Apple's iOS but Is It Really a Big Deal?
at The Street - Fri Jun 26, 11:44AM CDT
HBO Now is beating out rival video streamers in mobile revenue, but analysts say it's too soon to know if that should impress Wall Street.
NFLX: 114.31 (+2.75), AMZN: 536.15 (-0.61), P: 17.52 (+0.61), FOXA: 34.49 (+0.45), FV: 25.21 (+0.12), AAPL: 121.30 (-1.07), DISH: 64.61 (-0.37), TWX: 88.04 (-0.40)

The Zacks Analyst Blog Highlights: Shares MSCI USA Momentum Factor ETF, First Trust Dorsey Wright Focus 5 ETF and SPDR S&P 1500 Momentum Tilt ETF - Press Releases
Zacks Equity Research - Zacks Investment Research - Mon Jun 22, 8:30AM CDT
The Zacks Analyst Blog Highlights: Shares MSCI USA Momentum Factor ETF, First Trust Dorsey Wright Focus 5 ETF and SPDR S&P 1500 Momentum Tilt ETF
MMTM: 90.61 (+0.97), MTUM: 74.15 (+0.01), FV: 25.21 (+0.12)

Time for Momentum ETFs? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Jun 19, 12:00PM CDT
With risk-on sentiments getting stronger in the U.S. thanks to the indication of a gradual pace and trajectory of rate hike by the Fed, momentum ETFs worth a look.
MMTM: 90.61 (+0.97), MTUM: 74.15 (+0.01), FV: 25.21 (+0.12)

The Zacks Analyst Blog Highlights: JetBlue Airways, Credit Suisse Group, First Trust Dorsey Wright Focus 5 ETF and iShares MSCI USA Momentum Factor ETF - Press Releases
Zacks Equity Research - Zacks Investment Research - Thu May 21, 8:30AM CDT
The Zacks Analyst Blog Highlights: JetBlue Airways, Credit Suisse Group, First Trust Dorsey Wright Focus 5 ETF and iShares MSCI USA Momentum Factor ETF
MTUM: 74.15 (+0.01), CS: 29.45 (+0.01), JBLU: 22.98 (+0.12), FV: 25.21 (+0.12)

China ETFs Power Ahead In 2015; Gold, Silver Get Shine Back
at Investor's Business Daily - Tue May 19, 5:54PM CDT
Several sector ETFs have solar-powered investors to double-digit gains in 2015 so far. But for the brightest gains, Americans turned to foreign shores where China lords over all. U.S. equity exchange traded funds recovered in recent trading sessions...
SOCL: 19.03 (-0.18), BIIB: 318.78 (+1.78), CNXT: 43.62 (-0.03), XBI: 255.44 (+2.98), PES: 3.66 (-0.14), TAN: 35.32 (-0.73), FV: 25.21 (+0.12), UUP: 25.43 (-0.08), CELG: 131.25 (-0.63), SPY: 210.50 (-0.32), EOG: 77.19 (-1.35), SLV: 14.08 (-0.01), REGN: 553.66 (+6.56), ASHS: 48.39 (-0.31)

New Innovator IBD 50 ETF Makes Strong Debut
Zacks Funds - Seeking Alpha - Wed Apr 22, 4:07PM CDT
Actively managed ETFs have gained immense popularity in recent years and generally perform well in a world torn by strife and uncertainties. These represent just a small slice of the broad ETF world but aim to beat the benchmark index or the...
IWO: 154.95 (+1.24), PDP: 44.10 (+0.06), FV: 25.21 (+0.12), VBK: 134.91 (+0.63), FFTY: 25.20 (+0.06)

New Innovator IBD 50 ETF Makes Strong Debut - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Wed Apr 22, 9:00AM CDT
Have a look to the new ETF from Innovator that has easily crushed its peers in garnering investors attention in the initial days.
CNC: 70.13 (+0.20), CBM: 49.25 (-0.68), IWO: 154.95 (+1.24), PDP: 44.10 (+0.06), FV: 25.21 (+0.12), VBK: 134.91 (+0.63), PAYC: 32.00 (-0.22), FFTY: 25.20 (+0.06)

5 ETFs For A Retirement Portfolio
Zacks Funds - Seeking Alpha - Wed Apr 15, 4:10PM CDT
In an era of rock-bottom interest rates, retirement has become a lavish idea for many investors across the developed world. Earlier, people used to follow a rule of thumb for asset allocation between stocks and bonds, which said that the stock part...
SCHZ: 52.07 (+0.16), PID: 16.53 (unch), BSCK: 21.26 (+0.08), HEFA: 27.83 (+0.09), FV: 25.21 (+0.12)

5 ETFs for a Retirement Portfolio - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Apr 15, 1:02PM CDT
These ETFs could be the answer to a balance retirement portfolio.
SCHZ: 52.07 (+0.16), PID: 16.53 (unch), BSCK: 21.26 (+0.08), HEFA: 27.83 (+0.09), FV: 25.21 (+0.12)

Beat The Market With Momentum ETFs
Zacks Funds - Seeking Alpha - Mon Mar 23, 12:05PM CDT
Everyone loves a winner and that applies to stocks as well. While the popular finance theory "Random walk" states that the past movement of the price of a stock cannot be used to predict its future movement, history shows that recent past...
MTUM: 74.15 (+0.01), PDP: 44.10 (+0.06), FV: 25.21 (+0.12)

Zacks Investment Ideas feature highlights: First Trust Dorsey Wright Focus 5 ETF, iShares MSCI USA Momentum Factor ETF and PowerShares DWA Momentum Portfolio - Press Releases
Zacks Equity Research - Zacks Investment Research - Mon Mar 23, 8:30AM CDT
Zacks Investment Ideas feature highlights: First Trust Dorsey Wright Focus 5 ETF, iShares MSCI USA Momentum Factor ETF and PowerShares DWA Momentum Portfolio
MTUM: 74.15 (+0.01), PDP: 44.10 (+0.06), FV: 25.21 (+0.12)

Beat the Market with Momentum ETFs - ETF News And Commentary
Neena Mishra - Zacks Investment Research - Fri Mar 20, 11:48AM CDT
Buy high and sell higher--the mantra behind momentum investing works pretty well in the short run.
MTUM: 74.15 (+0.01), PDP: 44.10 (+0.06), FV: 25.21 (+0.12)

Biotech, Small-Cap ETFs Stand Out Among March Winners
at Investor's Business Daily - Tue Mar 17, 4:59PM CDT
Small-cap exchange traded funds were back in style among investors in recent weeks while leading U.S. multinationals such as Intel found the strengthening greenback is denting profits overseas. Stocks in the U.S. stumbled in the past 30 days. SPDR...
BIIB: 318.78 (+1.78), ACT: 298.98 (-2.94), XBI: 255.44 (+2.98), IBB: 382.53 (+3.73), TAN: 35.32 (-0.73), FV: 25.21 (+0.12), UUP: 25.43 (-0.08), DXJ: 57.45 (+0.39), HEDJ: 64.14 (+0.24), DWAS: 42.37 (+0.33), LCI: 59.60 (+0.16), FSLR: 44.30 (-1.01), HEWJ: 32.17 (+0.16), SPY: 210.50 (-0.32), DBJP: 42.60 (+0.23), BBH: 139.92 (+1.40), AAPL: 121.30 (-1.07)

Inside the New Target Factor ETFs from iShares - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jan 29, 5:00AM CST
iShares has recently launched two international ETFs based on momentum and quality factors.
IMTM: 27.55 (+0.06), GMOM: 24.70 (+0.09), MTUM: 74.15 (+0.01), IQLT: 27.07 (+0.38), QXUS: 48.94 (unch), QWLD: 62.65 (-0.27), PDP: 44.10 (+0.06), IDHQ: 20.83 (+0.42), FV: 25.21 (+0.12)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Fluence Energy Faces Leadership Departures Amid Legal Woes

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

SmallRig Boosts Art-Driven Innovation in AI Era

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Beko Pushes for Policy Synergy Amidst Carbon Shakeup

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...